SKI Market

Indian Indices

Sensex

85,063.34 -376.28
( -0.44%)

Global Indices

Nasdaq

49,005.54 602.14
(1.24%)

Dow Jones

6,922.69 43.22
(0.63%)

Hang Seng

52,499.37 666.57
(1.29%)

Nikkei 225

10,156.61 152.04
(1.52%)

Forex

USD-INR

90.04 0.08
(0.09%)

EUR-INR

105.51 -0.15
(-0.14%)

GBP-INR

121.16 -0.04
(-0.03%)

JPY-INR

0.57 0.00
(-0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

136.88

30.55

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Welspun Investments & Commercials standalone net profit declines 3.32% in the September 2025 quarter

Nov 06,2025

Net profit of Welspun Investments & Commercials declined 3.32% to Rs 3.49 crore in the quarter ended September 2025 as against Rs 3.61 crore during the previous quarter ended September 2024. Sales rose 0.41% to Rs 4.90 crore in the quarter ended September 2025 as against Rs 4.88 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	4.90	4.88	0
OPM %	93.27	98.77	-
PBDT	4.59	4.83	-5
PBT	4.59	4.83	-5
NP	3.49	3.61	-3

85,063.34 -376.28 ( -0.44%)

49,005.54 602.14 (1.24%)

6,922.69 43.22 (0.63%)

52,499.37 666.57 (1.29%)

10,156.61 152.04 (1.52%)

90.04 0.08 (0.09%)

105.51 -0.15 (-0.14%)

121.16 -0.04 (-0.03%)

0.57 0.00 (-0.01%)